Corona in general

Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2, the coronavirus that causes COVID-19. // 6.11.2021

Nature Genetics - SNP rs17713054 in the 3p21.31 COVID-19 risk locus is identified as a probable causative variant for disease association. // 4.11.2021

A new study discusses the entry of SARS-CoV-2 into the respiratory and olfactory mucosa of the nasal cavity. // 4.11.2021

Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene. // 3.11.2021

A new review article aimed to extract, review and summarize these articles from the mentioned databases to determine the link between SARS-CoV-2 infection and semen quality. // 3.11.2021

Scientists conducted a cohort study and measured the prevalence and the levels of antibody responses to the nucleocapsid protein of SARS-CoV-2 and four seasonal human coronaviruses. // 3.11.2021

A recent review of research published in the journal Diseases has shown that anti-inflammatory diets can be useful in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or reducing the severity of coronavirus disease 2019 (COVID-19). // 3.11.2021

In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago. // 3.11.2021

Researchers employ a stochastic quantitative microbial risk assessment model to assess risk reduction measures for controlling SARS-CoV-2 transmission. // 2.11.2021

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness. // 2.11.2021

Based on protein-protein interactions, the paper shows the presence of ten genes that overlap between the two illnesses, also shared by several other deadly and debilitating diseases. // 2.11.2021

Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants. // 2.11.2021

By studying a disease caused by a close cousin of the virus behind COVID-19, a team of scientists has identified a compound that shows potential in easing the symptoms of coronavirus infections. // 1.11.2021

A new study provides information on the associations between weather parameters and seasonal coronavirus cases. // 1.11.2021

Scientists explore the link between SARS-CoV-2 infection and anti-NMDAR encephalitis. // 1.11.2021

A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship. // 1.11.2021

A team of international scientists has recently identified a distinct set of proinflammatory mediators and metabolites associated with the fatal consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, they have established a link between gut microbiome alteration and hyper-inflammatory response in patients with severe COVID-19. // 1.11.2021

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19. // 31.10.2021

A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages. // 1.11.2021

Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes Covid-19. // 30.10.2021

Researchers reported regional variations on the impact of school reopening policy on the community rate of SARS-CoV-2 infection.// 29.10.2021

Study shows importance of vaccination to prevent severe disease, even among previously infected // 29.10.2021

A team of researchers conducted a randomized, placebo-controlled, adaptive platform trial to evaluate the efficacy of fluvoxamine to prevent COVID-19 progression and hospitalization. // 28.10.2021

COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researchers. This could affect responses to secondary infections. // 28.10.2021

A UBC-led research team has uncovered how the virus responsible for causing COVID-19 escapes destruction in infected cells, allowing SARS-CoV-2 to persist and continue spreading in the human body. // 27.10.2021

A new paper discusses neurologic symptoms in children with COVID-19. // 27.10.2021

Researchers find that the exponential spread of SARS-CoV-2 went largely unrecognized early on in 2020. // 27.10.2021

Research led by Sophie Meakin of the London School of Hygiene & Tropical Medicine in the United Kingdom suggests ensemble forecasts — a method combining multiple models to predict COVID-19 cases — may be more accurate in estimating COVID-19 hospital admissions in local areas. // 27.10.2021

Nature - Research conducted since the start of the pandemic is starting to suggest that the mouth could be a key player in COVID-19 infection. // 27.10.2021

A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a University of South Florida Health (USF Health) Morsani College of Medicine research team reports. // 26.10.2021